Skip to main content
Clinical Trials/NCT00699868
NCT00699868
Completed
Not Applicable

Cellular Immunity, Cytomegalovirus Infection and Septic Shock in ICU Patients

Assistance Publique Hopitaux De Marseille1 site in 1 country29 target enrollmentStarted: March 2008Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
29
Locations
1
Primary Endpoint
Bring to light the quantitative and qualitative immunological modifications of the present cells NK before the arisen of an infection to CMV

Overview

Brief Summary

This prospective study evaluate the immune status of patients admitted in ICU.CMV remains dormant in the body, but in people with immune deficiency, CMV could reactivate and cause life-threatening pneumonia.

Detailed Description

Candidates will be screened with medical history and blood tests.Then, 2 groups of 20 patients (with or without CMV reactivation) matched for CMV status will be compared for their immune system against CMV.

Study Design

Study Type
Interventional
Intervention Model
Parallel
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age more than 18-year-old
  • Informed consent

Exclusion Criteria

  • pregnant or lactating women,
  • adults under guardianship,
  • immunosuppression at the entrance to resuscitation,

Outcomes

Primary Outcomes

Bring to light the quantitative and qualitative immunological modifications of the present cells NK before the arisen of an infection to CMV

Time Frame: 24 months

Secondary Outcomes

  • Bring to light the quantitative and qualitative immunological modifications of cells NK in the consequences of an infectious shock(24 months)

Investigators

Study Sites (1)

Loading locations...

Similar Trials